Tuberculin, Purified Protein Derivative (Aplisol)
Tuberculin, Purified Protein Derivative is an FDA-licensed reference biologic from Endo Operations Limited. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1998
Reference approved
Reference product
Aplisol Tuberculin, Purified Protein Derivative
Endo Operations Limited
- Approved
- Apr 20, 1998
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Tuberculin, Purified Protein Derivative, in chronological order.
Reference approval
Approval date of the reference Tuberculin, Purified Protein Derivative product.
28 yr 6 mo ago
Frequently asked questions
Are there biosimilars approved for Tuberculin, Purified Protein Derivative (Aplisol)?
No 351(k) biosimilars or interchangeable biosimilars referencing Tuberculin, Purified Protein Derivative are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.